Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Glaucoma: Overview01:25

Glaucoma: Overview

1.2K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.2K
Photoreceptors and Visual Pathways01:22

Photoreceptors and Visual Pathways

8.6K
At the molecular level, visual signals trigger transformations in photopigment molecules, resulting in changes in the photoreceptor cell's membrane potential. The photon's energy level is denoted by its wavelength, with each specific wavelength of visible light associated with a distinct color. The spectral range of visible light, classified as electromagnetic radiation, spans from 380 to 720 nm. Electromagnetic radiation wavelengths exceeding 720 nm fall under the infrared category,...
8.6K
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

917
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
917
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

2.7K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
2.7K
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

1.1K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Should Oral Corticosteroids Be Used to Treat Demyelinating Optic Neuritis?

Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Societyยท2017
Same author

Multiple sclerosis: review of eye movement disorders and update of disease-modifying therapies.

Current opinion in ophthalmologyยท2015
Same author

Neuromyelitis optica.

Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Societyยท2012
Same journal

Key Considerations in Telestroke Program Management.

Continuum (Minneapolis, Minn.)ยท2026
Same journal

Neurology's Action Potential: Delivering on the Promise of Brain Health.

Continuum (Minneapolis, Minn.)ยท2026
Same journal

Erratum.

Continuum (Minneapolis, Minn.)ยท2026
Same journal

Management of Large Artery Atherosclerosis.

Continuum (Minneapolis, Minn.)ยท2026
Same journal

Thrombolysis, Thrombectomy, and Antithrombotic Therapy for Acute Ischemic Stroke.

Continuum (Minneapolis, Minn.)ยท2026
Same journal

Stroke in Children and Younger Adults.

Continuum (Minneapolis, Minn.)ยท2026
See all related articles

Related Experiment Video

Updated: Jan 6, 2026

Rat Model of Photochemically-Induced Posterior Ischemic Optic Neuropathy
14:54

Rat Model of Photochemically-Induced Posterior Ischemic Optic Neuropathy

Published on: November 29, 2015

9.0K

Ischemic Optic Neuropathy.

Mark J Morrow

    Continuum (Minneapolis, Minn.)
    |October 5, 2019
    PubMed
    Summary
    This summary is machine-generated.

    Recognizing ischemic optic neuropathy is crucial for preventing vision loss, particularly when giant cell arteritis (GCA) is suspected. Prompt diagnosis and treatment, including steroids for GCA, are essential for preserving sight.

    More Related Videos

    The Rodent Model of Nonarteritic Anterior Ischemic Optic Neuropathy rNAION
    06:49

    The Rodent Model of Nonarteritic Anterior Ischemic Optic Neuropathy rNAION

    Published on: November 20, 2016

    9.3K
    Author Spotlight: Developing Precise and Clinically Relevant Models for Studying Secondary Degeneration in Traumatic Optic Neuropathy
    04:02

    Author Spotlight: Developing Precise and Clinically Relevant Models for Studying Secondary Degeneration in Traumatic Optic Neuropathy

    Published on: November 29, 2024

    1.5K

    Related Experiment Videos

    Last Updated: Jan 6, 2026

    Rat Model of Photochemically-Induced Posterior Ischemic Optic Neuropathy
    14:54

    Rat Model of Photochemically-Induced Posterior Ischemic Optic Neuropathy

    Published on: November 29, 2015

    9.0K
    The Rodent Model of Nonarteritic Anterior Ischemic Optic Neuropathy rNAION
    06:49

    The Rodent Model of Nonarteritic Anterior Ischemic Optic Neuropathy rNAION

    Published on: November 20, 2016

    9.3K
    Author Spotlight: Developing Precise and Clinically Relevant Models for Studying Secondary Degeneration in Traumatic Optic Neuropathy
    04:02

    Author Spotlight: Developing Precise and Clinically Relevant Models for Studying Secondary Degeneration in Traumatic Optic Neuropathy

    Published on: November 29, 2024

    1.5K

    Area of Science:

    • Ophthalmology
    • Neurology
    • Vascular Medicine

    Background:

    • Acute ischemic optic neuropathy (ION) causes vision loss by damaging optic nerves, often affecting the anterior portion.
    • ION is linked to vascular risk factors and giant cell arteritis (GCA), a systemic inflammatory disease.

    Observation:

    • Optical coherence tomography (OCT) detects neural loss in ION earlier than funduscopic examination.
    • Advanced OCT visualizes optic nerve microvasculature, aiding pathogenesis research and diagnosis.
    • New diagnostic algorithms and cranial vascular imaging improve GCA likelihood assessment in ION patients.

    Findings:

    • Intraocular drug delivery shows promise for nonarteritic ION.
    • Immunologic agents offer steroid-sparing treatment options for GCA.
    • Prompt recognition of ION is vital for identifying GCA and initiating steroid therapy.

    Implications:

    • Early diagnosis of ION, especially GCA, necessitates immediate steroid treatment to prevent further vision loss.
    • Considering a broad differential diagnosis is critical to rule out other treatable conditions, particularly with retrobulbar ION.